Bariatric Surgery: Clinical Trials

6 trials for Bariatric Surgery, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed. 6 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 26Completed 6
Phase 11Completed 1

Follow Bariatric Surgery: new trials by email Literature Review of Bariatric Surgery trials Research Report on Bariatric Surgery

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Oral Acetaminophen for Post-Op Pain Management in Bariatric Surgery Patients
Acetaminophen - Post Operative Analgesia, Bariatric Surgery
Phase 2CompletedRutgers, The State University of New Jersey652024-11-132026-08-24
Study to Evaluate ARD-101 in Adults Receiving Bariatric Surgery
ARD-101 - Bariatric Surgery, Obesity
Phase 2CompletedAardvark Therapeutics, Inc.122022-03-012025-02-11
Zoledronic Acid for Prevention of Bone Loss After BAriatric Surgery (ZABAS)
Zoledronic Acid, Placebo - Bone Loss, Muscle Atrophy
Phase 2CompletedStinus Gadegaard Hansen592021-02-202026-06-01
Adjunct Phentermine + Topiramate After Bariatric Surgery in 12-24 Year Olds
Phentermine, Immediate Release Topiramate, Placebo for Phentermine - Obesity, Morbid, Bariatric Surgery
Phase 2CompletedUniversity of Colorado, Denver132020-01-152025-05-23
Rivaroxaban as Thrombosis Prophylaxis in Bariatric Surgery
Rivaroxaban 10 MG Oral Tablet [Xarelto] - Bariatric Surgery
Phase 2CompletedInsel Gruppe AG, University Hospital Bern2722018-07-192024-11-13
Regional TAP Block for Bariatric Patients
Transverse abdominal plane block, Ropivacaine - Bariatric Surgery, Transverse Abdominal Plane Regional Blocks
Phase 1 / Phase 2CompletedMontefiore Medical Center232013-04-012019-12-03

Narrower conditions

Agnosia (1)  ·  Bone Diseases, Metabolic (1)  ·  Muscular Atrophy (1)  ·  Obesity (1)  ·  Obesity, Morbid (1)  ·  Venous Thromboembolism (1)  ·  Weight Gain (1)

Broader conditions

Pathological Conditions, Signs and Symptoms (4)  ·  Signs and Symptoms (4)  ·  Nutritional and Metabolic Diseases (3)  ·  Body Weight (2)  ·  Nervous System Diseases (2)  ·  Neurologic Manifestations (2)  ·  Nutrition Disorders (2)  ·  Overnutrition (2)  ·  Overweight (2)  ·  Atrophy (1)  ·  Body Weight Changes (1)  ·  Bone Diseases (1)  ·  Cardiovascular Diseases (1)  ·  Embolism and Thrombosis (1)  ·  Metabolic Diseases (1)

Interventions

Acetaminophen (1)  ·  Phentermine (1)  ·  Rivaroxaban (1)  ·  Ropivacaine (1)  ·  Tablets (1)  ·  Topiramate (1)  ·  Zoledronic Acid (1)

Sponsors

Aardvark Therapeutics, Inc. (1)  ·  Insel Gruppe AG, University Hospital Bern (1)  ·  Montefiore Medical Center (1)  ·  Rutgers, The State University of New Jersey (1)  ·  Stinus Gadegaard Hansen (1)  ·  University of Colorado, Denver (1)

Countries

United States (4)  ·  Denmark (1)  ·  Switzerland (1)

Top investigators

Daniel T Abazia, PharmD (1)  ·  Guido Stirnimann, MD (1)  ·  Jaime M Moore, MD, MPH (1)  ·  Karina Gritsenko, MD (1)

Results publications

PMID 36209245, PMID 36413425, PMID 37227726, PMID 41177144

NIH funding

P30DK048520 (1)